PharmaCyte Biotech, Inc. (PMCB)

PharmaCyte Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 2, 2026	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Market Cap	7	8	17	2	2	1
Market Cap Growth	-35.59%	-50.55%	942.43%	1.57%	10.70%	5.15%
Enterprise Value	-13.13	-7.11	-21.27	-66.41	-83.79	-0.75
Last Close Price	0.69	1.24	2.12	2.92	2.33	27.43
PE Ratio	-	0.39	-1.18	-13.27	-0.29	-0.37
PB Ratio	0.19	0.16	0.62	0.02	0.02	0.22
P/TBV Ratio	0.13	0.18	0.74	0.02	0.01	0.20
P/FCF Ratio	-	-2.83	-7.92	-0.43	-0.39	-0.44
P/OCF Ratio	-	-2.83	-7.92	-0.43	-0.39	-0.44
EV/EBITDA Ratio	-	1.62	2.50	10.29	19.08	0.21
EV/EBIT Ratio	-	1.62	2.50	10.29	19.08	0.21
EV/FCF Ratio	-	2.39	9.89	17.50	20.35	0.22
Net Debt / Equity Ratio	-0.54	-0.30	-1.81	-0.94	-0.95	-0.33
Net Debt / EBITDA Ratio	3.81	3.55	5.89	10.54	19.45	0.61
Net Debt / FCF Ratio	4.28	5.22	23.32	17.93	20.74	0.66
Quick Ratio	12.24	6.60	6.76	115.99	121.24	3.04
Current Ratio	12.33	7.68	6.80	116.18	121.38	3.14
Return on Equity (ROE)	-8.64%	67.08%	0.59%	-5.31%	-8.78%	-60.35%
Return on Assets (ROA)	-9.63%	-7.61%	-12.79%	-7.88%	-8.96%	-53.39%
Return on Invested Capital (ROIC)	-14.85%	-19.32%	-128.61%	-140.80%	-97.64%	-82.84%
Return on Capital Employed (ROCE)	-9.92%	-8.36%	-13.61%	-7.94%	-9.09%	-61.33%
Earnings Yield	-101.06%	257.26%	-84.91%	-7.53%	-347.64%	-267.95%
FCF Yield	-	-35.34%	-12.63%	-232.09%	-255.84%	-229.11%
Buyback Yield / Dilution	3.58%	23.50%	-1751.81%	0.00%	-971.73%	-60.24%
Total Shareholder Return	3.58%	23.50%	-1751.81%	0.00%	-971.73%	-60.24%

Updated Jan 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q